|

SSGJ-705 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1
  • Shenyang Sunshine Pharmaceutical Co., LTD.1

Indications

  • Locally Advanced, Recurrent or Metastatic Malignancies2
  • Cancer2

Other2 trials

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
Phase 1
SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.